- Home
- CCTG vs NCEL Comparison
CCTG vs NCEL Comparison
Compare CCTG & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCTG | NCEL |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Hong Kong | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 20.7M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCTG | NCEL |
|---|---|---|
| Price | $0.13 | $2.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 618.1K | 90.5K |
| Earning Date | 12-23-2025 | 12-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,878,618.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.52 | N/A |
| 52 Week Low | $0.12 | $2.48 |
| 52 Week High | $2.61 | $7.64 |
Technical Indicators
Market Signals| Indicator | CCTG | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 28.67 | N/A |
| Support Level | $0.12 | N/A |
| Resistance Level | $0.21 | N/A |
| Average True Range (ATR) | 0.03 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 9.60 | 0.00 |
Price Performance
Historical ComparisonAbout CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.
About NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.